Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00453856Phase 4Terminated
A Phase 4 trial of sulfadoxine + pyrimethamine in Plasmodium falciparum malaria, sponsored by Albert Schweitzer Hospital. Started Mar 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00453856.